Hellow guys, Welcome to my website, and you are watching Type 2 Diabetes: The Effects of Different Antidiabetic Drug Classes on Mortality. and this vIdeo is uploaded by JAMA Network at 2018-07-12T10:06:09-07:00. We are pramote this video only for entertainment and educational perpose only. So, I hop you like our website.
| Name | Type 2 Diabetes: The Effects of Different Antidiabetic Drug Classes on Mortality |
| Video Uploader | Video From JAMA Network |
| Upload Date | This Video Uploaded At 12-07-2018 13:06:09 |
| Video Discription | This animated video summarizes a network meta-analysis of randomized clinical trials comparing the effects of SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors on mortality in patients with type 2 diabetes. Read the article at: https://ja.ma/2H8FpIo. Key Points: Question: How do sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl peptidase 4 (DPP-4) inhibitors compare in reducing mortality and cardiovascular events in patients with type 2 diabetes? Findings: In this network meta-analysis that includes 236 trials with 176 310 participants, the use of SGLT-2 inhibitors or GLP-1 agonists was significantly associated with lower all-cause mortality compared with the control groups (placebo or no treatment) (hazard ratio [HR], 0.80, and HR, 0.88, respectively) and with DPP-4 inhibitors (HR, 0.78, and HR, 0.86, respectively). Meaning: In patients with type 2 diabetes, the use of SGLT-2 inhibitors or GLP-1 agonists was associated with better mortality outcomes than DPP-4 inhibitors. |
| Category | People & Blogs |
| Tags | diabetes drugs | diabetic drugs | Diabetes Mellitus | Type 2 Diabetes | how diabetes drugs work | what are the best drugs for diabetes | Sodium-Glucose Cotransporter 2 Inhibitors | Glucagon-like Peptide 1 Agonists | Dipeptidyl Peptidase 4 Inhibitors | SGLT-2 inhibitors | GLP-1 agonists | DPP-4 inhibitors |
